Teva Pharmaceutical Indus Stock (NYSE: TEVA) stock price, news, charts, stock research, profile.
Open | $12.805 |
Close | $13.250 |
Volume / Avg. | 8.522M / 10.164M |
Day Range | 12.800 - 13.300 |
52 Wk Range | 7.085 - 14.465 |
Market Cap | $15.064B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NYSE |
RSI | 48 |
Short Interest | - |
Days to Cover | 1.53 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Teva Pharmaceutical Indus (NYSE: TEVA) through any online brokerage.
Other companies in Teva Pharmaceutical Indus’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Novartis (NYSE:NVS) and Pfizer (NYSE:PFE).
The latest price target for Teva Pharmaceutical Indus (NYSE: TEVA) was reported by JP Morgan on Friday, March 8, 2024. The analyst firm set a price target for 14.00 expecting TEVA to rise to within 12 months (a possible 5.26% upside). 15 analyst firms have reported ratings in the last year.
The stock price for Teva Pharmaceutical Indus (NYSE: TEVA) is $13.3 last updated April 25, 2024 at 6:38 PM EDT.
A quarterly cash dividend of $0.09 per share of Class A Common Stock. The quarterly cash dividend was payable on December 12, 2017 to stockholders of record on November 28, 2017.
Teva Pharmaceutical Indus’s Q1 earnings are confirmed for Wednesday, May 8, 2024.
There is no upcoming split for Teva Pharmaceutical Indus.
Teva Pharmaceutical Indus is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.